Search results for “Urokinase inhibitor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 295 patents, we discovered top 31 key players by total patent application. Heidelberg Pharma AG, Pfizer Inc., Abbott Laboratories are dominant in this area. They take 66.78% of the total patent filing.
Baden-Württemberg, Germany
Patent: 113
New York, United States
Patent: 61
Illinois, United States
Patent: 23
SURREY, United Kingdom
Patent: 11
Osaka-fu, Japan
Patent: 8
Germany
Patent: 8
Australia
Patent: 8
DSM IP Assets BV
Netherlands
Patent: 8
Tokyo-to, Japan
Patent: 7
Pennsylvania, United States
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1 patents applied in the last 5 years. We discover 1 most active companies in this area.
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1 patents in last 5 years, we discover 1 new entrants.
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 12 patents, we discovered top 4 universities and scientific research institutions by total patent application. Vlaams Instituut voor Biotechnologie - Flanders Institute, University of Antwerp, Friedrich Schiller University of Jena are dominant in this area. They take 75.00% of the total patent filing.
Belgium
Patent: 4
Antwerpen, Belgium
Patent: 3
Thüringen, Germany
Patent: 2
Fujian Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: